← All trials
NCT05360160
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 14, 2022
- Primary completion
- Dec 1, 2024
- Completion date
- Dec 1, 2024
- First posted
- May 4, 2022
- Last posted
- Oct 18, 2022
- Enrollment
- 43
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Texas at HoustonLead sponsor
- Syndax PharmaceuticalsCollaborator
- Astex Pharmaceuticals, Inc.Collaborator
- University of Texas at HoustonOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.